[Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic

Qin Yang1, Bing Han, Ru-Jia Xie

  • 1Department of Pathophysiology, Guiyang Medical College, Guiyang, China. qinyang@gmc.edu.cn

Insights

In diabetic nephropathy (DN) rats, elevated bone morphogenetic protein-7 (BMP-7) and inhibitory Smad expression in early stages may help regulate and limit kidney damage.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Endocrinology

Context:

  • Diabetic nephropathy (DN) is a significant complication of diabetes mellitus.
  • Understanding the molecular mechanisms underlying DN is crucial for developing effective treatments.

Purpose:

  • To investigate the expression of bone morphogenetic protein-7 (BMP-7) and inhibitory Smads (Smad6, Smad7) in the kidneys of rats with streptozotocin (STZ)-induced DN.
  • To explore the potential role of these molecules in the pathogenesis and progression of DN.

Summary:

  • STZ-induced DN in rats showed increased blood glucose, kidney weight, and urinary protein.
  • Early-stage DN exhibited elevated protein and mRNA expression of BMP-7 and inhibitory Smads (Smad6, Smad7).
  • Transforming growth factor-beta1 (TGF-beta1) and collagen type I (COL-I) mRNA levels were also increased in DN rats.

Impact:

  • The findings suggest that increased BMP-7 and inhibitory Smad expression in the early phase of DN may act as a protective feedback mechanism.
  • This regulatory response could potentially restrain the progression of kidney damage in diabetic nephropathy.